Home » Topics » BioWorld Science

BioWorld Science
RSS

Japanese approval sought for Trelegy Ellipta

May 29, 2018

Chugai seeks Japanese approval for Actemra for cytokine release syndrome

May 29, 2018

REXGEX trial shows importance of immune status for enhanced efficacy with CetuGEX

May 29, 2018

FDA grants priority review for gilteritinib NDA in relapsed or refractory AML

May 29, 2018

IDMC recommends continuation of phase III study of Zepsyre in small cell lung cancer

May 29, 2018

FDA approves Cimzia for the treatment of adults with moderate to severe plaque psoriasis

May 29, 2018

Arroyo BioSciences' AB-22 granted U.S. orphan drug designation for IPF

May 29, 2018

Tazemetostat granted U.S. orphan drug designation for chordoma

May 29, 2018

FDA grants orphan drug designation to SNX-5422 for neuroendocrine tumors

May 29, 2018

ImmuPharma releases further data analysis from pivotal trial of Lupuzor in SLE

May 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...